Intellectual-property model

Invent, protect, license.

CIVITERA realises value from intellectual property rather than from product distribution. This page sets out how a technology position moves from invention to an executed licence, and what is deliberately not published along the way.

Development

How a position is built.

Four stages, described at the level a counterparty needs to assess the model.

Invention

Technology positions are identified at the architectural layer, where the governance question is decided rather than implemented.

Protection

Positions are taken through patent applications filed at the United States Patent and Trademark Office. Filing detail, claim architecture and prosecution material are not published.

Public representation

Each technology is represented publicly at a non-enabling level: enough for a counterparty to assess relevance, never enough to reconstruct the technology.

Licensing

Engagement proceeds through defined stages, with confidentiality established before extended material is released.

The estate comprises 19 filed/pending U.S. patent applications; this site publishes 17 public technology profiles, which are communication artefacts rather than filing records. The two measure different things.

Engagement

Six ways a counterparty engages.

Which pathway applies depends on what the counterparty needs and what it is prepared to commit to. No commercial terms are published.

Technology licensing

Rights in filed and pending applications, licensed under defined field-of-use, territory and exclusivity terms.

Strategic partnership

Longer-form arrangements where a counterparty needs a governance position aligned with its own roadmap.

Co-development

Joint engineering of a technology position, with the treatment of resulting intellectual property agreed in advance.

Controlled diligence

Extended technical material released to qualified counterparties under executed confidentiality arrangements.

Evaluation and pilot pathways

Structured technical evaluation ahead of a commercial decision, on terms defined for the engagement.

Institutional implementation

Implementation within a public authority or institutional programme, on terms respecting jurisdictional control and oversight obligations.

Boundary

What the model does not disclose.

Stated explicitly rather than left to inference, so a counterparty knows where the public layer ends.

Technologies are represented publicly at a non-enabling level. Extended material is released only to qualified counterparties under executed confidentiality arrangements.

Not published
  • Claim architecture and filing strategy
  • Portfolio valuation models and royalty expectations
  • Negotiation methodology and commercial terms
  • Counterparty pipeline and unannounced discussions

Publicly available patent records may be independently verified through USPTO systems where applicable. Information concerning non-public applications is provided through controlled verification procedures to qualified counterparties.

Licensing

Begin a licensing discussion.

Qualified counterparties can engage the licensing division directly. Field of use, territory and exclusivity are settled within executed agreements.

Licensing modelThe portfolio